- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01857518
Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study (ADODEP)
Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study.
Adolescence is a critical period for the development of depressive disorders. As adolescence also is a critical period for brain maturation, it may be hypothesized that maturation changes in emotional circuits could underlie vulnerability for depression.
The aims of the study are (1) to identify the changes in brain morphometry, white matter microstructure, and functioning, in networks associated with depression features in adolescents, and (2) to assess the effects of treated pathology on brain structure by comparing the neuroimaging measures obtained in adolescents at inclusion with those at follow-up.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adolescence is a key development period for neurobiological processes underlying emotional and cognitive functions in adulthood. The pathophysiology of mood disorders has recently been associated with maturation changes in brain networks, but little is known on the early brain structure changes associated with depression appearing during this major brain maturation period.
The hypothesis of altered structural integrity of limbic prefrontal pathways emerges from the literature on depression, but it is unknown whether it is also detectable in adolescents with depression. Thus, we aim to investigate WM and GM structure and anatomy, and functional correlates of behavioral responses in depressed adolescents.
40 adolescents with a Major Depressive Episode will be investigated using structural T1 magnetic-resonance imaging and diffusion tensor imaging (DTI), at inclusion and after one-year follow-up. Additionally, they will be investigated with fMRI.
Covariation patterns between neuroimaging and behavioural/clinical variables will be assessed.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marie-Laure PAILLERE-MARTINOT, MD, PhD
- Phone Number: +33158412426
- Email: ml.paillere@cch.aphp.fr
Study Contact Backup
- Name: Marie GODARD
- Phone Number: 003345657728
- Email: m.godard@ch-sainte-anne.fr
Study Locations
-
-
-
Paris, France, 75006
- Recruiting
- Cochin Hospital
-
Contact:
- Marie-Laure PAILLERE, MD, PhD
- Phone Number: +33158412426
- Email: ml.paillere@cch.aphp.fr
-
Contact:
- Marie GODARD
- Phone Number: 0033145657728
- Email: m.godard@ch-sainte-anne.fr
-
Principal Investigator:
- Marie-Laure PAILLERE MARTINOT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Depressed adolescents:
Teenagers of both sexes, from 15 to 18 years old, without contreindications in magnetic fields
- affiliation to a Social insurance
- Informed consent signed by the holders of the parental rights (a specific information note to the teenager)
- Diagnosis DSM-IV-TR ( 2000 ) of depressive Disorder of the humor without psychotic characteristics. The symptoms will have to be persistent for 3 weeks, in spite of a coverage of support ( 2 consultations).
Exclusion Criteria:
- Ferromagnetical Material in the body
- Claustrophobia, Syndrom of post-traumatic stress, Obsessive-compulsive Disorder, Disturb Tricks, Disturbs abuse of substances
- Intrusive disorder of the development, Disturbs hyperactivity deficit of the attention, Disorders of the conducts, Schizophrenia
- Current antidepressant or antipsychotic psychotropic Treatment for more than 15 days in effective doses
- Current somatic pathology, or pregnancy (urinary test of pregnancy in case of doubt)
- Histories of cranial trauma or neurological pathology, or of lower born weight in 800g
- History of electroconvulsivotherapy in the previous 6 months
- Refusal to give his(her) consent or to be revised on one year after inclusion
Healthy adolescents: will be screened to be matched to the patients according to age and sex. They will have no psychiatric diagnosis, and no family history of psychiatric conditions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Depressed adolescents Group
Adolescents with a major depressive episode diagnosis
|
|
Other: Healthy adolescent control Group
Healthy adolescents recruited from general population
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evidence of white matter microstructure changes
Time Frame: Baseline
|
Statistical map of voxel-based analysis of white matter using tract based spatial statistics (TBSS) to compare depressed adolescents and healthy controls in emotional and reward networks
|
Baseline
|
Evidence of grey matter volume changes
Time Frame: Baseline
|
Statistical map of voxel-based analysis of grey matter using statistical parametric mapping (SPM8) to compare depressed adolescents and healthy controls in emotional and reward networks
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Correlation between Functional anatomy of emotional/reward responses and white matter and grey matter structure changes
Time Frame: Baseline
|
Baseline
|
Grey matter and white matter changes in frontal limbic networks at follow-up in treated patients
Time Frame: Follow-up one year
|
Follow-up one year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marie-Laure PAILLERE MARTINOT, MD, PhD, APHP
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-A01466-37
- D500 (Other Identifier: CHSA)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent Depression
-
University of North Carolina, Chapel HillFoundation of Hope, North CarolinaRecruiting
-
Creighton UniversityThrasher Research FundCompletedAdolescent DepressionUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)RecruitingAdolescent Depression | Adolescent SuicideUnited States
-
University of North Carolina, Chapel HillNational Center for Complementary and Integrative Health (NCCIH)CompletedAdolescent Behavior | Resilience, Psychological | Depression MildUnited States
-
University of British ColumbiaCompletedEducation of Therapists Treating Adolescent DepressionCanada
-
University of North Carolina, Chapel HillUniversity of Colorado, Denver; Doris Duke Charitable Foundation; University... and other collaboratorsNot yet recruitingDepression | Anxiety | Adolescent Behavior | Mental Health Issue | Psychosocial Functioning | Adolescent - Emotional ProblemIndia
-
Washington University School of MedicineWashington University Institute of Clinical and Translational SciencesCompletedAnxiety Disorders | Adolescent DepressionUnited States
-
Montana State UniversityCompletedStress | Depression, Anxiety | Adolescent BehaviorUnited States
-
University of MinnesotaCompleted
-
MaineHealthGlaxoSmithKlineTerminated
Clinical Trials on -Diagnostic, clinical and psycho-behavioral assessments -Neuroimaging: T1-MRI, DTI-MRI, fMRI
-
Karolinska InstitutetUnknownAttention Deficit Hyperactivity Disorder | Healthy Controls | Emotional Instability Personality Disorder (Borderline Personality Disorder)
-
Olaf BlankeUniversity Hospital, Geneva; University Hospital Inselspital, Berne; Centre Hospitalier... and other collaboratorsUnknown